For the first time, this study identifies a role for fractalkine in the recruitment of T cells to the inflamed omentum of EAC patients implicating this chemokine as a player and potential therapeutic target in pathological T cell-mediated inflammation in obesity and obesity-associated malignancies. The gene discussed is CX3CL1; the disease is obesity due to melanocortin 4 receptor deficiency.